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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312 S227Conclusions: Our ﬁndings show that (a) Wnt/b-catenin signaling acts
anti-catabolic in human articular chondrocytes and especially inhibits
NF-kB-mediated catabolic events, whereas Wnt/b-catenin signaling in
mouse articular chondrocytes stimulates catabolic events, and that (b)
AnxA6 via stimulating NF-kB activity and inhibiting Wnt/b-catenin
signaling plays a major role in human cartilage degradation during OA
pathology. Our ﬁndings suggest that targeting AnxA6 function, espe-
cially its modulatory function of the NF-kB andWnt/b-catenin signaling
pathways may be a more effective way to control these signaling
pathways and their interactions during OA pathology than targeting
these individual pathways directly.
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CONTRAST-BASED MICRO-CT ANALYSIS OF MMP INHIBITOR
EFFICACY IN A RAT OSTEOARTHRITIS MODEL
T. Thote y, N.J. Willett y, M.A. Hart z, A.S. Lin y, S. Moran y, R.E.
Guldberg y, R.V. Kamath z. yGeorgia Inst. of Technology, Atlanta, GA,
USA; zAbbott Lab., Worcester, MA, USA
Purpose: Osteoarthritis (OA) is the most common degenerative joint
disease in humans and there are currently no clinically viable disease
modifying osteoarthritis drugs (DMOADs). Previous studies have tested
matrix metalloproteinase inhibitors (MMPis) in different animal models
and demonstrated efﬁcacy. In these studies, histopathology analysis has
been used as the traditional method to evaluate efﬁcacy of MMPi's. This
technique is time consuming, 2D, requires large samples sizes and
semi–quantitative. Equilibrium Partitioning of an Ionic Contrast Agent
based micro-CT (EPIC-mCT) imaging can be used to nondestructively
quantify changes in articular cartilage but has not previously been
applied to evaluate the efﬁcacy of DMOADs. Objective: Evaluate the
efﬁcacy of a broad spectrum MMPi (ABT-518 from Abbott Laboratories,
Abbott Park, IL) in the rat medial meniscal tear (MMT) model using
EPIC-mCT based quantitative parameters. Hypothesis: EPIC-mCT
provides a sensitive method to detect therapeutic effects of MMP
inhibition in a rat OA model.
Methods: Animal model: Weight matched male Lewis rats (275-300g)
were separated in three groups: Sham surgery, MMT +MMPi (30 mg/kg
orally twice a day for 21 days) and MMT+ vehicle (n¼14-15). All
surgeries were performed at Abbott Laboratories and approved by the
IACUC. m-CT Imaging: Joints were dissected and scanned following
equilibration in Hexabrix contrast agent. Images were evaluated for 3
volumes of interest (VOIs): (1) Only osteophytes (2) Medial 1/3 region of
medial tibial plateau cartilage (3) Only focal cartilage lesions (defect >
50% of cartilage thickness) on the medial plateau. Statistics: Data are
shown as means  SEM and analyzed via t-test or one-way ANOVA
(GraphPad Prism5 Software)
Results: Osteophyte: Representative coronal grayscale CT images show
the osteophytes in the vehicle MMT group compared to the MMPi
treated and sham group (Fig 1).
Figure 1. Delineation of osteophyte (OP) and representative images from experimental
groups.Quantitative EPIC-mCT showed signiﬁcantly higher total periph-
eral volume, mineralized peripheral volume, cartilaginous peripheral
volume and average 3D peripheral thickness in the vehicle MMT group
compared to MMPi treated group (Fig 2). No evidence of osteophytes
was observed in the sham animals. Cartilage: Representative imagesshow delineation of the medial 1/3 tibial plateau from the medial tibial
plateau and illustration of lesion vs. erosion sites (Fig 3 A, B). Cartilage
volume increased at 3 weeks in the vehicle MMT and MMPi treated
groups compared to the shams (Fig 3C). Lesion volumewas signiﬁcantly
lower in the MMPi group compared to the vehicle MMT group (Fig 3D).
The shams showed no lesions on the articular surface.
Figure 2. Quantiﬁcation of osteophyte parameters.Ă
Figure 3. Evaluation of medial 1/3 cartilage volume and lesion volume.ĂPower
analysis: A power analysis was performed to measure the minimum
number of samples required to detect differences in osteophyte
development between theMMPi treated and vehicle MMTgroups. Post-
hoc power analysis based on total peripheral volume indicated that
a minimum of 5 animals would be needed per group to detect
a signiﬁcant difference at a power > 0.8 and a ¼ .05.
Conclusions: In summary, 3D image analyses of retrieved joints indi-
cated that MMPi reduces focal lesion volume and osteophyte develop-
ment. Power analyses showed that the effects of the MMPi treatment
could be detected with as few as 5 samples per group when using EPIC-
mCT. This is the ﬁrst study to demonstrate the use of EPIC-mCTas a tool to
study efﬁcacy of potential DMOADs in rat MMT model of OA.
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BISPHOSPHONATE USE REDUCES PAIN AND RADIOLOGICAL
PROGRESSION IN PATIENTS WITH SYMPTOMATIC AND
RADIOGRAPHIC KNEE OSTEOARTHRITIS: DATA FROM THE
OSTEOARTHRITIS INITIATIVE
L.L. Laslett y, S.R. Kingsbury y, E.M. Hensor y, M.A. Bowes z, P.G.
Conaghan y. yUniv. of Leeds, Leeds, United Kingdom; z Imorphics Ltd,
Manchester, United Kingdom
Background: Bisphosphonate use has been studied in patients with OA,
with apparent mixed results. Effects on bone have generally been
positive: an observational study reported a 90% reduction in odds of
having a bone marrow lesion (BML) with the use of alendronate (OR
0.11, p0.05), whilst risedronate (50mg weekly) prevented an increase
in BML size over 24 months although this did not reach statistical
signiﬁcance. Risedronate (15 mg) reduced markers of cartilage
